More UK residents that received the AstraZeneca vaccine developed blood clots than initially believed, officials said, as German officials recommend avoiding the brand when it comes to booster shots.
Britain’s Medicines and Healthcare products Regulatory Agency announced Thursday that it has recorded 30 blood clot cases, a huge jump from the previous tally of five.
It included 22 reports of cerebral venous sinus thrombosis, an extremely rare brain ailment, and eight reports of other clotting events associated with low blood platelets soon after getting the controversial jab.
It was not clear how seriously ill the 30 became, although there have been reports of deaths elsewhere in Europe, where more than a dozen nations have stopped using AstraZeneca’s drug.
The UK has yet to receive a single report of such a clot in those getting the BioNTech and Pfizer jabs.
Health officials still say the benefits of fighting COVID-19 with the AstraZeneca shot outweigh the risks, noting that the 30